Medicines
Find medicines for human use by name or active substance.
Browse by initial
Medicines beginning with G
281–300 of 564 medicines
-
-
-
GLIBOMET 2.5mg/400mg film-coated tablets GUIDOTTI
Active substance: glibenclamide + metformin
Indicated for: type 2 diabetes mellitus
-
GLIBOMET 400mg/2.5mg film-coated tablets GUIDOTTI
Active substance: metformin + glibenclamide
Indicated for: type 2 diabetes mellitus
-
GLICLAZID LPH 80mg tablets LABORMED
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZID MR LPH 30mg prolonged-release tablets LABORMED
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA ACTAVIS 30mg modified release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA ACTAVIS 60mg modified release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA ATB 30mg prolonged-release tablets ANTIBIOTICE
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA EP ANTIBIOTICE 30mg prolonged-release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA GAMMA 30mg modified release tablets WORWAG
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA GEMAX PHARMA 60mg prolonged-release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA GENERICS 30mg modified release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA GENTIAN GENERICS 30mg modified release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA JELFA 30mg prolonged-release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA KRKA 60mg modified release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA LUPIN 60mg prolonged-release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA MEDREG 60mg prolonged-release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA MR TERAPIA 30mg prolonged-release tablets
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
-
GLICLAZIDA POLPHARMA 30mg modified release tablets PHARMACEUTICAL WORKS
Active substance: gliclazide
Indicated for: type 2 diabetes mellitus
About medicines
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.